Craniotomy Completed Phase 1 / 2 Trials for Labetalol (DB00598)

IndicationStatusPhase
DBCOND0021273 (Craniotomy)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01408524Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and DiltiazemTreatment